March 18, 2020 09:58 AM EDTUpdated March 19, 04:31 AM
R&D
Coronavirus

Covid-19 roundup: Trump back­tracks on NIH/CDC fund­ing, No­var­tis launch­es $20M fund, FDA and ICER can­cel­la­tions

Jason Mast

Editor

An­oth­er day, an­oth­er batch of coro­n­avirus news. To­day: A $20 mil­lion Big Phar­ma pledge, new vac­cine and drug hunts, and can­cel­la­tions from ICER and the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Halozyme with­draws Evotec ac­qui­si­tion pro­pos­al af­ter biotech is 'un­will­ing to en­gage'

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times